Viva Biotech Announces 2019 Interim Results
Revenue grew significantly by 83.9% YoY from RMB77.4 million to approximately RMB142.3 million. Gross profit recorded approximately RMB71.9 million, growing significantly by 70.0% from RMB42.3 million. Net profit excluding extraordinary profit or loss increased significantly by 47.4% YoY from approximately RMB66.9 million to approximately RMB98.6 million. Basic adjusted Non-IFRS earnings per share recorded RMB0.08, and the Board of Directors recommend...